Oxford Gene Technology Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
164
- Latest Deal Type
-
M&A
Oxford Gene Technology General Information
Description
Provider of genetics research and biomarker services based in Begbroke, United Kingdom. The company's genetics research and biomarker services offer genomic technologies that help in solid tumor panel and RNA sequencing, and also assist in gene expression analysis, enabling clinical and academic research industries to accurately identify causative variation underlying genetic diseases.
Contact Information
Website
ogt.co.uk(Operating Subsidiary)
Corporate Office
- Unit 5, Oxford Technology Park
- 4A Technology Drive
- Kidlington OX5 1GN
- England, United Kingdom
Corporate Office
- Unit 5, Oxford Technology Park
- 4A Technology Drive
- Kidlington OX5 1GN
- England, United Kingdom
Oxford Gene Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 02-Jun-2017 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2012 | Completed | Generating Revenue | |||
| 3. Grant | 21-Jun-2011 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jan-1995 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-1995 | Completed | Startup |
Oxford Gene Technology Comparisons
Industry
Financing
Details
Oxford Gene Technology Competitors (20)
One of Oxford Gene Technology’s 20 competitors is Unchained Labs, a Private Equity-Backed company based in Pleasanton, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Unchained Labs | Private Equity-Backed | Pleasanton, CA | ||||
| Asuragen | Formerly VC-backed | Austin, TX | ||||
| Yikang Medical (Laboratory Services) | Private Equity-Backed | Suzhou, China | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA |
Oxford Gene Technology Patents
Oxford Gene Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201208726-D0 | Methods and materials | Inactive | 17-May-2012 | ||
| US-20150141277-A1 | Methods of quantifying of nucleic acids captured on a solid support | Inactive | 17-May-2012 | ||
| EP-2850206-A1 | Methods of quantifying of nucleic acids captured on a solid support. | Inactive | 17-May-2012 | ||
| WO-2013171511-A1 | Methods of quantifying of nucleic acids captured on a solid support. | Inactive | 17-May-2012 | ||
| GB-201000315-D0 | Combined cgh & allele specific hybridisation method | Inactive | 08-Jan-2010 |
Oxford Gene Technology Signals
Oxford Gene Technology Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Union | Government | |||
| Innovate UK | Government | |||
| Oxford Spin-out Equity Management | Venture Capital | Minority | ||
| Oxford University Innovation | Corporation | Minority | ||
| University of Oxford | University |
Oxford Gene Technology Investments & Acquisitions (3)
Oxford Gene Technology’s most recent deal was a Merger/Acquisition with Cytocell Technologies. The deal was made on 14-Feb-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cytocell Technologies | 14-Feb-2014 | Merger/Acquisition | Other Healthcare Services | ||
| Sense Proteomic | 17-Mar-2009 | Merger/Acquisition | Drug Discovery | ||
| Sense Proteomic | 19-Nov-1998 | Spin-Off | Drug Discovery |
Oxford Gene Technology Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sense Proteomic | Maidenhead, United Kingdom | 1998 |
Oxford Gene Technology FAQs
-
When was Oxford Gene Technology founded?
Oxford Gene Technology was founded in 1995.
-
Where is Oxford Gene Technology headquartered?
Oxford Gene Technology is headquartered in Kidlington, United Kingdom.
-
What is the size of Oxford Gene Technology?
Oxford Gene Technology has 164 total employees.
-
What industry is Oxford Gene Technology in?
Oxford Gene Technology’s primary industry is Discovery Tools (Healthcare).
-
Is Oxford Gene Technology a private or public company?
Oxford Gene Technology is a Private company.
-
What is Oxford Gene Technology’s current revenue?
The current revenue for Oxford Gene Technology is .
-
Who are Oxford Gene Technology’s investors?
European Union, Innovate UK, Oxford Spin-out Equity Management, Oxford University Innovation, and University of Oxford are 5 of 6 investors who have invested in Oxford Gene Technology.
-
Who are Oxford Gene Technology’s competitors?
Unchained Labs, Asuragen, Yikang Medical (Laboratory Services), Ambry Genetics, and Standard BioTools are some of the 20 competitors of Oxford Gene Technology.
-
When was Oxford Gene Technology acquired?
Oxford Gene Technology was acquired on 02-Jun-2017.
-
Who acquired Oxford Gene Technology?
Oxford Gene Technology was acquired by Sysmex (Diagnostic Equipment).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process